Meibomian Gland Dysfunction Clinical Practice Guidelines

Shiro Amano¹, Jun Shimazaki², Norihiko Yokoi³, Yuichi Hori⁴, Reiko Arita⁵; Committee for Meibomian Gland Dysfunction Clinical Practice Guidelines

Collaborators, Affiliations

Collaborators

Committee for Meibomian Gland Dysfunction Clinical Practice Guidelines:
Hiroto Obata, Motoko Kawashima, Shizuka Koh, Takashi Suzuki, Tomo Suzuki, Masahiko Yamaguchi, Masakazu Yamada, Takashi Itokawa, Hiroko Iwashita, Tomohiko Usui, Miki Uchino, Fumika Oya, Yukinobu Okajima, Minako Kaido, Koji Kakisu, Yuichi Kaji, Hiroaki Kato, Eiki Goto, Aoi Komuro, Yuri Sakane, Chika Shigeyasu, Sayaka Sumazaki, Seika Den, Yukiko Nagahara, Yasuhito Hayashi, Masatoshi Hirayama, Masaki Fukui, Shima Fukuoka, Yuka Hosotani, Naoyuki Morishige, Yasuto Sato, Akiko Yagami, Atsushi Shiraishi, Kazutaka Kamiya, Mika Noda, Takeshi Soma

Affiliations

¹ Ochanomizu Inoue Eye Clinic, 4-3 Kandasurugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. Amanoshiro1126@gmail.com.
² Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.
³ Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
⁴ Department of Ophthalmology, Toho University Omori Medical Center, Tokyo, Japan.
⁵ Ito Clinic, Sakura, Japan.

PMID: 37351738
DOI: 10.1007/s10384-023-00995-8

Editorial

Meibomian Gland Dysfunction Clinical Practice Guidelines

Shiro Amano et al. Jpn J Ophthalmol. 2023 Jul.

. 2023 Jul;67(4):448-539.

doi: 10.1007/s10384-023-00995-8. Epub 2023 Jun 23.

Authors

Shiro Amano¹, Jun Shimazaki², Norihiko Yokoi³, Yuichi Hori⁴, Reiko Arita⁵; Committee for Meibomian Gland Dysfunction Clinical Practice Guidelines

Collaborators

Committee for Meibomian Gland Dysfunction Clinical Practice Guidelines:
Hiroto Obata, Motoko Kawashima, Shizuka Koh, Takashi Suzuki, Tomo Suzuki, Masahiko Yamaguchi, Masakazu Yamada, Takashi Itokawa, Hiroko Iwashita, Tomohiko Usui, Miki Uchino, Fumika Oya, Yukinobu Okajima, Minako Kaido, Koji Kakisu, Yuichi Kaji, Hiroaki Kato, Eiki Goto, Aoi Komuro, Yuri Sakane, Chika Shigeyasu, Sayaka Sumazaki, Seika Den, Yukiko Nagahara, Yasuhito Hayashi, Masatoshi Hirayama, Masaki Fukui, Shima Fukuoka, Yuka Hosotani, Naoyuki Morishige, Yasuto Sato, Akiko Yagami, Atsushi Shiraishi, Kazutaka Kamiya, Mika Noda, Takeshi Soma

Affiliations

¹ Ochanomizu Inoue Eye Clinic, 4-3 Kandasurugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. Amanoshiro1126@gmail.com.
² Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.
³ Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
⁴ Department of Ophthalmology, Toho University Omori Medical Center, Tokyo, Japan.
⁵ Ito Clinic, Sakura, Japan.

PMID: 37351738
DOI: 10.1007/s10384-023-00995-8

No abstract available

PubMed Disclaimer

Cited by

Standardization of meibomian gland dysfunction in an Egyptian population sample using a non-contact meibography technique.
Karara AM, El-Sanabary Z, El-Helw MA, Macky TA, Abdelhakim MASE. Karara AM, et al. Int J Ophthalmol. 2024 Jan 18;17(1):61-65. doi: 10.18240/ijo.2024.01.08. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38239941 Free PMC article.
The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction.
Beatty CJ, Ruiz-Lozano RE, Quiroga-Garza ME, Perez VL, Jester JV, Saban DR. Beatty CJ, et al. Ocul Surf. 2024 Apr;32:81-90. doi: 10.1016/j.jtos.2024.01.004. Epub 2024 Jan 14. Ocul Surf. 2024. PMID: 38224775 Free PMC article.
Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Corneal, Oculoplastic, and Orbital Surgery.
Wu KY, Kearn N, Truong D, Choulakian MY, Tran SD. Wu KY, et al. Adv Exp Med Biol. 2025;1483:69-114. doi: 10.1007/5584_2025_855. Adv Exp Med Biol. 2025. PMID: 40131704 Review.
Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study.
Xu H, Kang Q. Xu H, et al. Int J Gen Med. 2025 Jul 31;18:4169-4179. doi: 10.2147/IJGM.S529713. eCollection 2025. Int J Gen Med. 2025. PMID: 40766860 Free PMC article.
Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction.
Shimazaki J, Kito G, Kamoi M, Satake Y. Shimazaki J, et al. Jpn J Ophthalmol. 2024 Sep;68(5):472-481. doi: 10.1007/s10384-024-01079-x. Epub 2024 Jul 13. Jpn J Ophthalmol. 2024. PMID: 39002075 Free PMC article.

See all "Cited by" articles

References

1. Amano S, Arita R, Kinoshita S, Yokoi N, Sotozono C, Komuro A, et al. Definition of meibomian gland dysfunction and proposal of diagnostic criteria. J Eye. 2010;27:627–31 (in Japanese).
1. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52:1922–9. - PubMed - PMC - DOI
1. Hwang HS, Parfitt GJ, Brown DJ, Jester JV. Meibocyte differentiation and renewal: insights into novel mechanisms of meibomian gland dysfunction (MGD). Exp Eye Res. 2017;163:37–45. - PubMed - PMC - DOI
1. Amano S, Inoue K. Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017;58:1283–7. - PubMed - DOI
1. Amano S, Inoue K. Estimation of prevalence of meibomian gland dysfunction in Japan. Cornea. 2017;36:684–8. - PubMed - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Meibomian Gland Dysfunction Clinical Practice Guidelines

Collaborators

Affiliations

Meibomian Gland Dysfunction Clinical Practice Guidelines

Authors

Collaborators

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical